Global VP, Portfolio Strategy & Access Insights

Cari

København

Hybrid

DKK 2,500,000 - 3,800,000

Full time

3 days ago

Be an early applicant

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

Novo Nordisk in Copenhagen, Denmark, seeks a GVP to lead Portfolio Strategy, Insights & Access with global scope. You will translate market insights into strategic direction, guide executive decision-making and shape investments across therapy areas.

You will collaborate with R&D, Medical, Finance and Commercial leaders to align portfolio priorities with patient access and financial value while guiding cross-functional teams to deliver impactful outcomes.

Qualifications

MBA, MSc, PhD, PharmD or MD, or degree in Economics/Public Health or equivalent.
15–20+ years of experience in strategy, consulting, pharmaceuticals, market access, forecasting or portfolio management.
Experience presenting to executive leadership and governance boards, with strong storytelling for decision forums.
Proven people leadership and stakeholder management experience with large, diverse, cross-functional teams.
Strong strategic, commercial and analytical capabilities – data-driven and able to make decisions under uncertainty.
Ability to balance patient impact, access considerations and financial outcomes.
Confidence to challenge and influence C‑suite and SVP‑level stakeholders.

Responsibilities

Define and drive long-term portfolio strategies across therapy areas, assessing pipeline, lifecycle management and business development opportunities.
Lead strategic evaluations of portfolio investments and prioritisation and bring clear recommendations to Executive Management and governance committees.
Translate market, customer (healthcare professionals, patients and consumers), competitor and healthcare system insights into actionable direction, supported by ongoing competitive intelligence and horizon scanning.
Shape long-range forecast assumptions, scenario planning and business cases for pipeline assets, launches and strategic investments to support resource allocation.
Integrate payer, reimbursement and HTA considerations into portfolio decisions and make sure access strategies are reflected in development and commercialisation plans.
Raise the quality and speed of decision support by improving scenario planning methods, competitive assessment approaches and shared decision frameworks.
Provide strategic leadership across NPP, Early Pipeline & Exploratory, helping shape the future portfolio and translate early opportunities into clear strategic choices.